#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    ABO haemolytic disease of newborn Pulmonary sarcoidosis Encephalopathy neonatal Fibrosarcoma Candida infection Atopic keratoconjunctivitis Extra-osseous Ewing's sarcoma Anti-glomerular basement membrane disease Liposarcoma recurrent Paget's disease of the vulva Glioblastoma multiforme Neurodevelopmental disorder Thalassaemia B-cell type acute leukaemia Primitive neuroectodermal tumour More trials…

    Learn about Rare Diseases

    Ornithine transcarbamoylase deficiency – Diagnostics Cystic fibrosis – Diagnostics Piriformis syndrome – Diagnostics Netherton’s syndrome – Diagnostics Pemphigoid – Diagnostics Glycogen storage disease type I Pemphigus – Life with Disease Prader-Willi syndrome – Treatment CADASIL – Life with Disease Splenic marginal zone lymphoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ANOC-001 Fosfomycin Trometamol Alanine Ondansetron Hydrochloride Pilocarpine Nitrate Tazemetostat Ganaxolone Gallium Citrate Ga-68 Dopamine Hydrochloride Pimecrolimus Somatostatin SALICYLIC ACID Brigatinib Copper (64Cu) Chloride Dermatophagoides Farinae Tioguanine Nomegestrol Acetate Fludarabine Phosphate Ph. Eur. Evx-01 EGANELISIB More therapies…

    Learn about Your Condition

    Infection Pharyngeal cancer stage II Gaucher's disease type I Mitochondrial myopathy Sinusitis bacterial Amyotrophic lateral sclerosis Left ventricular failure Bipolar I disorder Epileptic encephalopathy Hepatorenal syndrome Oral lichen planus Malignant melanoma stage IV Adrenal insufficiency Cardiovascular disorder Postoperative wound infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Pembrolizumab and Radiotherapy for Patients with Limited Spread of Head and Neck Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Pembrolizumab
    Belgium Italy Spain

  • Study on the Use of Landiolol Hydrochloride and Sodium Chloride for Patients Undergoing Mitral Valve Surgery to Prevent Low-Cardiac Output Syndrome

    Recruiting

    3 1 1
    Investigated Drugs:
    • Landiolol Hydrochloride
    • Sodium Chloride
    Italy

  • Title: Study of TAR-0520 gel for skin rash (folliculitis) caused by cancer treatment with EGFR inhibitors in colorectal cancer patients

    Recruiting

    2 1
    Investigated Diseases:
    • Drug eruption
    Investigated Drugs:
    • Brimonidine Tartrate
    France

  • Study on the Effectiveness and Safety of Ivermectin Cream Compared to a Drug Combination for Patients with Papulopustular Rosacea

    Recruiting

    3 1 1
    Investigated Diseases:
    • Papulopustular rosacea
    Investigated Drugs:
    • Ivermectin
    Germany

  • Study on Ependymoma Treatment in Children, Adolescents, and Young Adults Using Cisplatin, Cyclophosphamide, Etoposide, and a Drug Combination

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Ependymoma
    Investigated Drugs:
    • Sodium Valproate
    • Cisplatin
    • Cyclophosphamide
    Austria Belgium Czechia Denmark Finland France +7

  • Study on Chemotherapy with Irinotecan, Fluorouracil, and Oxaliplatin for Patients with Metastatic Colorectal Cancer After Surgery or Ablation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Disodium Folinate
    • Calcium Folinate Pentahydrate
    • Capecitabine
    Germany
Previous Page
1 … 417 418 419 420 421 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!